Zipline selected as 2019 Red Herring Top 100 North America Winner

ZipLine Medical, Inc. was selected as a winner of the Red Herring Top 100 North America award, which recognizes the continent's most exciting and innovative private technology companies.

Winners were chosen from thousands of entrants in a gamut of verticals, from financial technology to marketing, and medical devices to Internet of things. Companies were judged by industry experts, insiders and journalists on a wide variety of criteria, including financial performance, innovation, business strategy, and market penetration. Red Herring’s editors have been evaluating the world’s startups and tech companies for over two decades and their insights enable them to select firms that will continue on a trajectory to success. Brands such as Alibaba, Google, Kakao, Skype, Spotify, Twitter and YouTube have all been singled out as Red Herring winners in the past.

The Zip® Surgical Skin Closure and PreLoc Wound Closure devices have seen significant adoption in key surgical procedures such as total joint replacement and limb salvage. In addition to the economic benefits these devices provide to the hospital and clinic, the high degree of patient satisfaction they engender has created word of mouth that often drives a patient’s friends and family to request ZipLine devices for their next surgery.

"Adoption of the Zip device in our procedures represents the cutting edge of surgery. Orthopedic patients are becoming more and more educated on the products and techniques that offer the best surgical outcomes, and come to the table expecting these from their surgeon," said Robert C. Marchand MD, orthopedic surgeon and robotic joint replacement expert in Wakefield, Rhode Island. "The Zip enables us to provide patients with a more comfortable recovery and better cosmetic outcome while reducing surgical procedure time and patient complications that add costs to the healthcare system.

ZipLine Medical, Inc.

ZipLine Medical, Inc.
Post-surgical wound closure devices

Downloads

DownloadPress Release

Latest News

HLS Therapeutics announces Health Canada grants medical device license for CSAN PRONTO

HLS Therapeutics Inc. announces that Health Canada has granted a medical device license for the Athelas One WBC System, marketed as CSAN PRONTO, for use as a point-of-care device indicated for quantitative determination of white blood cells and neutrophil percentages in capillary or venous whole blood.

Valneva Completes Recruitment for Phase 2 Studies of its Lyme Disease Vaccine Candidate VLA15

Valneva has announced that it has completed patient recruitment of the Phase 2 studies for its Lyme disease vaccine candidate, VLA15.

Baxter Announces Acquisition of Cheetah Medical

Baxter International Inc., a leading global medical products company, today entered into a definitive agreement to acquire Cheetah Medical, a leading provider of non-invasive hemodynamic monitoring technologies

Zipline announces positive results from two significant clinical studies

ZipLine Medical, Inc. has announced publication of positive results from two significant clinical studies in two peer- reviewed journals demonstrating that use of Zip® Surgical Skin Closure leads to better clinical outcomes and healthcare cost savings than do surgical staples

Valneva reports strong operational performance and major corporate progress with H1 2019 results

Valneva has reported that its H1 2019 results are marked by strong operational performance and major corporate progress; regaining control of key R&D assets and strengthening its financial outlook with $23 million CEPI chikungunya grant

Valneva initiates second Phase II study for its Lyme Disease vaccine candidate

Valneva has announced the initiation of the second study of Phase 2 clinical development for its leading, unique Lyme disease vaccine candidate VLA15